Posted in | News | Business | Mining

Rio Tinto's Divestments Top US$10 Billion

Rio Tinto's divestment programme has passed the US$10 billion mark with the completion of the sale of its Alcan Packaging Food Americas division to Bemis Company, Inc for a total all cash consideration of US$1.2 billion.

Guy Elliott, chief financial officer Rio Tinto, said: "Our balance sheet has been transformed in the past twelve months on the back of the divestment programme, the rights issues and continued strong operating cash flows. The recapitalisation leaves Rio Tinto well placed to consider value adding investment opportunities as they emerge."

Rio Tinto has now completed divestments in excess of $10 billion, with over $7 billion having been completed since the beginning of 2009, predominantly for cash. In 2008, Rio Tinto completed divestments totalling US$3.1 billion. In 2009, Rio Tinto completed asset sales of US$3.7 billion. In 2010, the Group has completed divestments of US$3.5 billion comprising Alcan Packaging Food Americas, Alcan Packaging global Pharmaceuticals, global Tobacco, Food Europe and Food Asia divisions, Vickery (Coal & Allied) and Maules Creek (Coal & Allied).

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Amcor PLC. (2019, February 10). Rio Tinto's Divestments Top US$10 Billion. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=20852.

  • MLA

    Amcor PLC. "Rio Tinto's Divestments Top US$10 Billion". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=20852>.

  • Chicago

    Amcor PLC. "Rio Tinto's Divestments Top US$10 Billion". AZoM. https://www.azom.com/news.aspx?newsID=20852. (accessed November 21, 2024).

  • Harvard

    Amcor PLC. 2019. Rio Tinto's Divestments Top US$10 Billion. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=20852.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.